By zoolligakampung
Diabetes Drug Gets FDA Warning Due to Amputation Risk
WEDNESDAY, May 17, 2017 (HealthDay News) The type 2 diabetes prescription drug canagliflozin (brand names Invokana, Invokamet, Invokamet XR) appears to increase the risk of leg and foot amputations, the U.S. Food and Drug Administration now says. The FDA is requiring the medications to carry new...
generalhealth, diabetesdrug, invokana, news
You’re about to leave Blogged.my for an external website we don’t control. Its content is the responsibility of its author, not an endorsement by us.
We’ll take you there in a moment. Logged-in members go straight to posts — why not sign up?